IPSEN – Buy-back programme – Art 5 of MAR – Week 38 – 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 38 – 2023
Aggregated presentation by day and by market
IPSEN – Buy-back programme – Art 5 of MAR – Week 38 – 2023
- 26 September 2023 - 1 mins read
Aggregated presentation by day and by market
Related Press Releases

11 July 2024
6 mins read
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential

09 July 2024
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 27 – 2024

09 July 2024
1 mins read
Ipsen – June 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital

08 July 2024
1 mins read
Half-year statement of IPSEN liquidity agreement – 2024 06 30

02 July 2024
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 26 – 2024

02 July 2024
9 mins read
Ipsen expands collaboration and license agreement for development of Cabometyx® in advanced neuroendocrine tumors based on positive CABINET Phase III trial

25 June 2024
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 25 – 2024

18 June 2024
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 24 – 2024

11 June 2024
1 mins read
IPSEN – Buy-back programme – Art 5 of MAR – Week 23 – 2024

10 June 2024
12 mins read